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Exposure of cells or organs to sublethal physical or chemical stresses induces disruption of cellular structures and functions. Here, we
examined whether Na+-glucose cotransporter (SGLT1) is involved in the recovery from heat shock (HS) injury in porcine renal epithelial
LLC-PK1 cells. Recovery from HS (42 jC for 3 h, then 37 jC for 12 h) increased SGLT1 activity, assessed by [
14C]a-methyl
glucopyranoside uptake, and a maximal transport rate (Vmax) from 2.4 to 5.9 nmol/mg protein/30 min, but did not alter an apparent affinity
constant (Km). Protein distribution of SGLT1 in apical membrane fraction was also increased after recovery from HS without changing in
total membrane fraction. Membrane integrity assessed by calcein accumulation was decreased by HS, and then returned to basal level. This
recovery was inhibited by phloridzin, a potent SGLT1 inhibitor, and nonmetabolizable glucose analogues. Anti-transforming growth factor-
h1 (TGF-h1) antibody inhibited both elevation of SGLT1 distribution in apical membrane and recovery of calcein accumulation induced by
HS. Taken together, HS increases in the number of SGLT1 protein in apical membrane mediated via TGF-h1 signaling pathway. The increase
of glucose uptake is necessary to repair plasma membrane integrity.
D 2003 Elsevier B.V. All rights reserved.Keywords: Heat shock; Kidney; Membrane integrity; SGLT1
+1. Introduction
Stress- or injury-induced protection and functional en-
hancement are often associated with increased synthesis and
accumulation of heat-shock proteins (HSPs) [1–3]. Some
HSPs can be ascribed to the need for assistance in protein
folding, trafficking, and controlled degradation. It is, how-
ever, unknown what kinds of mechanisms are involved in
the recovery of their functions and morphology. The kidney
has the potential for recovery from the acute loss of function
after ischemia or toxicants [4,5]. Cellular damages induced
by chemicals and heat shock are estimated by increase in
membrane permeability [6], denaturation of membrane and
cytoskeletal proteins [7], and collapse of cytoskeletal pro-
teins [8,9]. These damages affect the function of various ion0167-4889/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
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E-mail address: ikari@u-shizuoka-ken.ac.jp (A. Ikari).transport pathways such as Na -glucose cotransporter [10–
12], Na+-K+-ATPase [12], and Na+-Pi cotransporter [13] so
that these transporters may be involved in the recovery from
cellular injury.
Recovery from heat shock (HS) injury led to activation of
Na+-dependent glucose transport in renal epithelial cell line,
LLC-PK1 [10,11]. So far, it has been reported that two types
of Na+-glucose cotransporter (SGLT1 and SGLT3) are
expressed in LLC-PK1 cells and over 85% of total Na
+-
dependent glucose transport is mediated by SGLT1 [14,15].
In kidney, SGLT1 is located in the late proximal tubule and
reabsorbs the remainder of filtered glucose not reabsorbed in
the early proximal tubule [16]. The expression of SGLT1
may be regulated by some intracellular factors because the
renal expression level is lower than that in small intestine.
We recently found that Na+-dependent glucose transport was
elevated by transforming growth factor-h1 (TGF-h1) [13]
and inhibited by angiotensin II [17]. However, the regulatory
mechanisms of SGLT1 and roles except for reabsorption of
Na+ and glucose have not been determined in detail.
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by which HS increases SGLT1 activity in LLC-PK1 cells.
We also examined the role of SGLT1 during recovery
from HS injury.Fig. 1. Elevation of Hsp70 by HS in LLC-PK1 cells. (A) Total membrane
fractions were prepared from the cells of preheat (P) and HS followed by
recovery for 0 and 12 h. Samples were immunoblotted with anti-Hsp70
antibody (upper) or anti-actin antibody (lower).2. Materials and methods
2.1. Cell culture
The porcine renal epithelial LLC-PK1 cells were obtained
from the Japanese Collection of Research Bioresources Cell
Bank (Tokyo, Japan). Cells were maintained in Medium 199
(Sigma, St. Louis, MO, USA) supplemented with 10% fetal
calf serum (FCS), 0.07 mg/ml penicillin G potassium, and
0.14 mg/ml streptomycin sulfate in an atmosphere of 5%
CO2 in air at 37 jC. Cells were exposed to HS (42 jC for 3
h) and recovered (37 jC for indicated time) in FCS-free
medium.
2.2. SDS-polyacrylamide gel electrophoresis and Western
blotting
LLC-PK1 cells were harvested before, just after HS, and
after 12-h recovery. The total and the apical membrane
fractions were prepared as described by Turner and Moran
[18]. Protein concentration was measured using the protein
assay kit (Bio-Rad Laboratories, CA, USA) with bovine
serum albumin as the standard. SDS-polyacrylamide gel
electrophoresis was carried out as previously described
[19]. In brief, membrane preparations (30 Ag) were applied
to the SDS-polyacrylamide (10%) gel. A monoclonal anti-
Hsp70 antibody (SPA-810) was obtained from StressGen
Biotechnologies (Victoria, BC, Canada). A polyclonal anti-
actin antibody (C-11) was from Santa Cruz Biotechnology
(Santa Cruz, CA, USA). A polyclonal anti-SGLT1 antibody
was kindly provided from Prof. Julia E. Lever (University
of Texas Medical School, Houston, USA). Proteins were
blotted onto a PVDF membrane and incubated for 1.5
h with each primary antibody, then incubated for 1.5 h with
horseradish peroxidase-conjugated anti-mouse IgG, anti-
rabbit IgG, or anti-goat IgG, respectively. Finally, the blots
were stained with the ECL Western blotting kit (Amersham
Biosciences, Buckinghamshrine, UK). The band density
was quantified using the public domain NIH image 1.61
program (developed at the U.S. National Institutes of
Health and available on the Internet at http://rsb.info.nih.
gov/nih-image/).
2.3. Measurement of SGLT1 activity
Cells were grown to confluent density on 24-well
plates, and then exposed to HS for 3 h. The SGLT1
activity was assayed by incubating in a modified Hank’s
balanced salt solution (HBSS) containing 0.5 mM unla-
beled a-methyl glucopyranoside (AMG), 0.4 ACi/ml[14C]AMG (NEN Life Science Products, MA, USA), 137
mM NaCl, 0.34 mM Na2HPO4, 4.17 mM NaHCO3, 0.44
mM KH2PO4, 5.7 mM KCl, 1.29 mM CaCl2, 0.81 mM
MgSO4, and 10 mM HEPES, pH 7.4, in the presence and
absence of 0.5 mM phloridzin, a potent SGLT1 inhibitor.
For determination of kinetic parameters of SGLT1 activity,
unlabeled AMG concentrations were varied from 0.01 to 1
mM. After incubation at 37 jC for 30 min, the solution
was quickly aspirated and washed by ice-cold HBSS
without [14C]AMG four times. At the concentration used
in the present study, the uptake of [14C]AMG was linear
with the incubation time over 30 min. The cells were
solubilized with 0.5 N NaOH and the aliquots were taken
for determination of radioactivity and protein concentra-
tion. The phloridzin-sensitive [14C]AMG uptake was about
80.3F 1.0% (n = 5) of total uptake.
2.4. Determination of fluorescent dye accumulation
The cells grown on 96-well plates were exposed to
HS and recovery from HS. As indicated, the media were
replaced with Dulbecco’s minimal essential medium
(DMEM) (Sigma) containing glucose or nonmetabolizable
glucose analogues, 2-deoxyglucose or AMG. Then, the
cells were incubated with HBSS containing 1.5 AM
calcein-tetraacetoxymethyl ester (calcein-AM) (Dojindo
Laboratories, Kumamoto, Japan) at 37 jC for 20 min.
The calcein-AM is a membrane-permeable and nonfluo-
rescent dye. Fluorescent calcein accumulates in the
cytoplasm after cleavage of calcein-AM by endogenous
esterases and leaks out according to the membrane
injury. To estimate the amount of calcein accumulation,
Fig. 2. Effects of HS on SGLT1 activity in LLC-PK1 cells. (A) LLC-PK1
cells were exposed to normal temperature (P) or HS followed by recovery
for 0, 3, 6, and 12 h. SGLT1 activity was determined by [14C]AMG uptake
carried out at 37 jC for 30 min. All data were subtracted by a nonspecific
[14C]AMG transport in the presence of 0.5 mM phloridzin. The number of
experiments is 4. **P < 0.01 and *P < 0.05 vs. normal temperature. (B)
SGLT1 activity was determined in the cells of preheat (n) and HS followed
by recovery for 0 h (E) and 12 h (o). Unlabeled AMG concentrations were
varied from 0.01 to 1 mM. The number of experiments is 3. *P < 0.05 vs.
preheat cells.
Fig. 3. Effects of HS on SGLT1 expression in LLC-PK1 cells. (A,B) Total
membrane (A) and apical membrane fractions (B) were prepared from the
cells of preheat (P) and HS followed by recovery for 0 and 12 h. Samples
were immunoblotted with anti-SGLT1 antibody. (C) The band densities of
Western blotting of total membrane fraction and apical membrane fraction
were quantified with NIH image 1.61. The apical SGLT1/total SGLT1 ratio
under preheat condition was taken as 1. The number of experiments is 3.
**P < 0.01 vs. preheat cells.
A. Ikari et al. / Biochimica et Biophysica Acta 1643 (2003) 47–53 49the cells were solubilized with 2% Triton X-100 after
collecting extracellular solution. Both extracellular and
intracellular fluorescence intensity of calcein was mea-
sured with excitation at 485 nm and emission at 538 nm
using a Fluoroskan Ascent CF (Thermo Labsystems,
Finland).
2.5. Measurement of cell proliferation
The cells grown on 96-well plates were incubated with
HBSS containing 5 Ag/ml Hoechst 33342 (Sigma) at 37 jC
for 120 min or 1 Ag/ml rhodamine 123 at 37 jC for 30 min.
As indicated, the cells were preliminarily exposed to HS and
recovered from HS. The fluorescence intensity of Hoechst
33342 was measured with excitation at 385 nm and emis-
sion at 460 nm using a Fluoroskan Ascent CF.2.6. Measurement of lactate dehydrogenase (LDH) activity
The cells grown on 24-well plates were preliminarily
exposed to HS or recovered from HS. After collecting the
extracellular solution, the cells were solubilized with 2%
Triton X-100. LDH activity was assessed by the appended
protocol of LDH reagent kit (Sigma). LDH release was
represented as a percentage of total LDH activity (intracel-
lular plus extracellular activities).
2.7. Statistics
Results are presented as meansF S.E. Differences be-
tween the groups were analyzed by one-way analysis of
variance (ANOVA), and correction for multiple compari-
sons was made using Turkey’s multiple comparison test. If
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was considered to be significant.3. Results
3.1. Elevation of SGLT1 activity by HS in LLC-PK1 cells
LLC-PK1 cells are utilized to examine the mechanisms of
glucose reabsorption in renal proximal tubules. At the
confluent density, the uptake of [14C]AMG (SGLT1 activ-
ity) and the expression of SGLT1 were observed in LLC-
PK1 cells [11]. At first, we checked the induction of Hsp70
by HS. Hsp70 was increased after HS and 12-h recovery in
the present experimental conditions (Fig. 1). HS did not
affect the expression of actin. Next, we examined the effect
of HS on SGLT1 activity. SGLT1 activity was slightlyFig. 4. Recovery of calcein accumulation from HS injury. (A) The cells
were exposed to HS followed by recovery for 0, 1.5, 3, and 12 h in the
presence (closed circle) and the absence (open circle) of 0.5 mM phloridzin.
Then, the cells were incubated with calcein-AM at 37 jC for 20 min. After
removing extracellular calcein, the cells were solubilized by 2% Triton X-
100. The aliquot was collected and calcein accumulation was normalized to
a reference sample of preheat (P). (B) Calcein release was determined by
collecting extracellular solution. The amount of calcein release was about a
one-fourth of total calcein fluorescence intensity. The number of experi-
ments is 4. **P< 0.01 vs. 1.5 h.
Fig. 5. Effects of nonmetabolizable glucose analogues on calcein
accumulation. (A) The cells were incubated with DMEM containing
glucose (open circle), 2-deoxyglucose (closed circle), or 3-o-methyl-
glucopyranoside (closed triangle). Then, the cells were exposed to HS
followed by recovery for 0, 1.5, 3, and 12 h and incubated with calcein-
AM at 37 jC for 20 min. After removing extracellular calcein, the cells
were solubilized by 2% Triton X-100. The aliquot was collected and
calcein accumulation was normalized to a reference sample of preheat (P).
(B) Calcein release was determined by collecting extracellular solution.
The amount of calcein release was about one-fourth of total calcein
fluorescence intensity. The number of experiments is 4. **P< 0.01 and
*P< 0.05 vs. 1.5 h.decreased by HS although it was not significantly different
from preheat cells (P>0.05), then increased above preheat
level (Fig. 2A). The SGLT1 activity after 12-h recovery
increased about 1.7 times of preheat cells. For the measure-
ment of kinetic parameters of SGLT1, the concentration of
unlabeled AMG was varied from 0.01 to 1 mM, and the
curve was fitted using the Michaelis–Menten equation (Fig.
2B). An apparent affinity constant (Km) for AMG was 0.31
mM and a maximal rate of transport (Vmax) was 2.4 nmol/
mg protein/30 min in the cells before HS exposure (n = 4).
The Vmax value slightly decreased right after HS (Km: 0.31
mM; Vmax: 2.1 nmol/mg protein/30 min). After 12-h recov-
ery from HS, the Vmax value increased to 5.9 nmol/mg
protein/30 min without changing of the Km value (0.35 mM,
P>0.05).
Fig. 6. Effects of HS on cell proliferation. The cells were exposed to HS
followed by recovery for 0, 1.5, 3, and 12 h in the presence (hatched
column) or absence (open column) of 0.5 mM phloridzin. Then, the cells
were incubated with Hoechst 33342 at 37 jC for 30 min. Fluorescence
intensity was normalized to a reference sample of preheat cells (P). The
number of experiments is 3.
Fig. 7. Effects of HS on LDH release. (A) The cells were exposed to normal
temperature (P) or HS followed by recovery for 0, 1.5, 3, and 12 h in the
presence (hatched column) or the absence (open column) of 0.5 mM
phloridzin. LDH released into the extracellular solution was represented as
a percentage of total LDH activity. (B) The cells were incubated with
DMEM containing 5.5 mM glucose (open column), 5.5 mM 2-
deoxyglucose (hatched column), or 5.5 mM AMG (closed column). Then,
the cells were exposed to HS followed by recovery for 0–12 h. The number
of experiments is 4.
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fraction by HS
The expression level of SGLT1 protein in the total
membrane fraction did not significantly change just after
HS and after 12-h recovery from HS (Fig. 3). However, the
distribution level of SGLT1 protein in the apical membrane
fraction increased after 12-h recovery from HS. This pattern
is similar to the elevation of SGLT1 activity, suggesting that
the increased amount of SGLT1 in the apical membrane
induced elevation of SGLT1 activity.
3.3. Effects of HS on plasma membrane integrity
To examine the effects of HS on the membrane integrity,
we measured calcein accumulation and LDH release. Cal-
cein accumulation did not change just after HS, but de-
creased after 1.5-h recovery (Fig. 4A). Then, it returned to
the basal level during 12-h recovery. In contrast, calcein
release transiently increased after 1.5-h recovery and
returned to the basal level during 12-h recovery (Fig. 4B).
The recovery of both calcein accumulation and release was
inhibited by phloridzin, a potent SGLT1 inhibitor. Further-
more, the replacement of glucose with nonmetabolizable
glucose analogues, 2-deoxyglucose or AMG, significantly
inhibited the recovery of calcein accumulation (Fig. 5).
These results indicate that glucose uptake mediated via
SGLT1 is necessary to recover the plasma membrane injury.
To exclude the possibility that the elevation of calcein
accumulation was caused by increase of cell number, we
checked the cell proliferation using DNA-binding fluores-
cent dye, Hoechst 33342 [20]. HS and 12-h recovery from
HS did not increase the cell number (Fig. 6), indicating thatthe increase of calcein accumulation reflects membrane
integrity. Next, we examined the effects of HS and glucose
in culture media on LDH release. HS did not affect LDH
release compared with preheat cells (Fig. 7A). Furthermore,
the addition of phloridzin and the replacement of glucose
with 2-deoxyglucose or AMG did not significantly alter
LDH release. These results suggest that the injury of plasma
membranes by HS was minor since the small calcein
molecule passed.
3.4. Involvement of TGF-b1 in HS responses
We recently reported that HS induced secretion of TGF-
h1 and led to an increase of SGLT1 activity in LLC-PK1
cells [11]. Neither HS nor TGF-h1, however, increased
SGLT1 expression in the total membrane fraction. In the
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apical membrane fraction was significantly increased by
recovery from HS (Fig. 8A,B). These results are parallel to
those in TGF-h1-treated cells as shown by immunocyto-
chemistry [11]. An anti-TGF-h1 antibody inhibited the HS-
induced SGLT1 distribution in the apical membrane. Fur-
thermore, anti-TGF-h1 antibody significantly inhibited the
recovery of calcein accumulation (Fig. 8C). These results
indicate that TGF-h1 is involved in the elevation of SGLT1
activity, which could help the recovery of plasma membrane
injury induced by HS.Fig. 8. Inhibition of HS responses by anti-TGF-h1 antibody. (A) Apical
membrane fractions were prepared from the cells of preheat (P) and HS
followed by recovery for 12 h in the presence (+) and absence ( ) of anti-
TGF-h1 antibody. Samples were immunoblotted with anti-SGLT1 antibody.
(B) The band density of Western blotting was quantified with NIH image
1.61 and normalized to that of preheat cell. The number of experiments is 3.
*P < 0.05 vs. presence of anti-TGF-h1 antibody. (C) The cells were
exposed to HS followed by recovery for 0, 1.5, 3, and 12 h in the presence
(closed circle) or the absence (open circle) of anti-TGF-h1 antibody.
Calcein accumulation was normalized to a reference sample of preheat (P).
The number of experiments is 4. **P< 0.01 and vs. 1.5 h.4. Discussion
Renal tubular epithelial cells are exposed to various
stresses such as oxidants, ischemia, and toxicants so that
the cells must have ingenious mechanisms to protect them
from injury and recover their normal morphology and
function [21,22]. The protective mechanisms have been
investigated and characterized well, but the recovery mech-
anisms are unknown. Sussman and Renfro [10] reported that
HS enhanced Na+-glucose cotransport and provided a pro-
tective effect against severe injury in LLC-PK1 cells. There
are no data as to whether the function of SGLT1 is linked
with the recovery of cellular injury or cytoprotection.
SGLT1 is mainly expressed in small intestine and
kidney [16]. A low-affinity and high-capacity Na+-depen-
dent glucose transporter (SGLT2) is also expressed in
kidney. The distribution of SGLT1 and SGLT2 are differ-
ent; SGLT1 is located in the proximal straight tubules (S2
and S3 segments), and SGLT2 in proximal convoluted
tubule (S1 segment). SGLT2 is known to reabsorb glucose
because the majority of filtered glucose is reabsorbed in S1
segment [23]. Contrarily, the function of renal SGLT1 is
obscure because it is located in the proximal straight
tubules that are less likely to reabsorb glucose and are
expressed at lower levels than the small intestine. Interest-
ingly, HS enhanced SGLT1 activity and its distribution in
the apical membrane after 12-h recovery from HS in LLC-
PK1 cells (Figs. 2 and 3). We hypothesized that SGLT1 is
involved in recovery from cellular injury caused by various
stresses.
To clarify a novel function of SGLT1, we examined the
involvement of SGLT1 in the recovery of membrane integ-
rity after HS injury. In the same time course with the
activation of SGLT1, HS altered the calcein accumulation
and release (Figs. 4 and 5). Phloridzin, a potent SGLT1
inhibitor, and nonmetabolizable glucose analogues inhibited
the recovery of calcein accumulation. This recovery was not
due to cell proliferation (Fig. 6), indicating that it reflects a
decrease in membrane permeability. Cell damage sometimes
occurs due to the loss of high-energy phosphate compounds
(ATP). Aerobic and anaerobic metabolism each account for
f 50% of basal ATP production in cultured collecting duct
cells [24]. ATP production rate was increased by HS within
1 h, and returned to basal level within 3 h in rat inner
medullary collecting duct cells [6]. We also observed that
ATP content was transiently increased by HS and returned
to the basal level after 12-h recovery in LLC-PK1 cells (data
not shown). There is a discrepancy in the time course
between SGLT1 activity and ATP content. Furthermore,
total LDH activity that carried the final step of glycolysis
was not changed by HS and recovery from HS (data not
shown). SGLT1 is suggested to be involved in the repair of
plasma membranes injured by HS without affecting ATP
concentration and glycolysis. We need further study to
clarify the mechanisms of by which SGLT1 repairs mem-
brane integrity.
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duction in LLC-PK1 cells [11]. The elevation of SGLT1
activity was consistent with the elevation of SGLT1 distri-
bution in the apical membrane (Fig. 8). An anti-TGF-h1
antibody inhibited both elevation of SGLT1 activity and its
distribution in the apical membrane. Furthermore, the re-
covery of calcein accumulation was also inhibited by the
antibody. TGF-h1 is multifunctional cytokine implicated in
renal diseases [25] and acts to increase matrix production
and inhibit matrix degradation in glomerulonephritic rats.
On the contrary, cytokines have been suggested to play a
role in normal repair process in kidney [26] and pancreatic
duct [27]. Our data indicate that SGLT1 activation is one of
the pathways involved in the repair of membrane injury by
TGF-h1.
In conclusion, HS injury enhanced SGLT1 activity and
expression in the apical membranes of LLC-PK1 cells.
Plasma membranes lost integrity by HS injury, but recov-
ered as mediated by SGLT1 activation. TGF-h1 is involved
in both elevation of SGLT1 activity and recovery of mem-
brane integrity. It may be important to restrict the concen-
tration of TGF-h1 within the adequate range to maintain
renal physiological functions because TGF-h1 has two
kinds of contrary effects.Acknowledgements
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